{"id":"W2335878298","doi":"10.1111/dom.12640","title":"Low incidence of anti‐drug antibodies in patients with type 2 diabetes treated with once‐weekly glucagon‐like peptide‐1 receptor agonist dulaglutide","year":2016,"lang":"en","type":"article","venue":"Diabetes Obesity and Metabolism","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":27,"is_retracted":false,"has_abstract":true,"ca_institutions":"Eli Lilly (Canada)","funders":"Eli Lilly and Company","keywords":"Dulaglutide; Medicine; Agonist; Pharmacology; Internal medicine; Exenatide; Type 2 diabetes; Gastroenterology; Endocrinology; Receptor; Diabetes mellitus","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0008421483,0.0001271056,0.0004947258,0.0003016194,0.0002216901,0.000410228,0.0001226645,0.0002801004,0.0007548468],"category_scores_gemma":[0.002378622,0.0001361617,0.000290501,0.0003548231,0.0001482886,0.000337633,0.0001680035,0.0004311939,0.00008663867],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001670322,"about_ca_system_score_gemma":0.0001726177,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000421239,"about_ca_topic_score_gemma":0.000678153,"domain_scores_codex":[0.9993943,0.0002411738,0.00008953642,0.00008947701,0.0001383494,0.00004712203],"domain_scores_gemma":[0.9983723,0.0004489447,0.0008263447,0.00007800448,0.00009894669,0.0001755636],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.00206358,0.0001885901,0.9797651,0.00004464982,0.0001026268,0.0002642173,0.00007557525,0.00007465838,0.002350271,0.00001741566,0.0001300338,0.01492328],"study_design_scores_gemma":[0.0001583686,0.002221409,0.9946976,0.00001206833,0.00008207627,0.001546633,0.00008060961,0.0002957087,0.0004468753,0.00002565821,0.0004277175,0.000005376422],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9984972,0.0008255178,0.0001079435,0.00003203751,0.000007103023,0.00001382762,0.00005545889,0.000004552438,0.0004562796],"genre_scores_gemma":[0.9995096,0.0001952264,0.00008364095,0.00005305156,0.00001189368,0.000007141581,0.00006674417,0.000001206797,0.00007147779],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0008421483,"threshold_uncertainty_score":0.004453778,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.006900930693368485,"score_gpt":0.2257974279227052,"score_spread":0.2188964972293367,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}